Is BDRX or BHVN more undervalued in 2026?

CirclFi compares Biodexa Pharmaceuticals plc (BDRX) and Biohaven Ltd. (BHVN) using 13 institutional-grade valuation models. BDRX has a Quality of Company score of 1.7/10 while BHVN scores 3.8/10.

Which is a better buy — BDRX or BHVN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BDRX and BHVN valuations compare?

BDRX at $3.36 and BHVN at $10.24 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BDRX vs BHVN Valuation Comparison 2026 — Intrinsic Value Analysis

BDRX

Biotechnology

Biodexa Pharmaceuticals plc

Quality

1.7

out of 10

Value Trap

—

Price

$3.36

Last close

Models

6/13

Active

BHVN

Biotechnology

Biohaven Ltd.

Quality

3.8

out of 10

Value Trap

LOW

Price

$10.24

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	BDRX Fair Value	BDRX Upside	BHVN Fair Value	BHVN Upside
Bayesian DCF	Intrinsic	$0.89	-73.5%	$2.84	-72.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.04	-7.9%	—	—
Dynamic NAV	Asset-Based	$16.83	+413.0%	$2.20	-78.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BDRX vs BHVN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BDRX vs BHVN — Which Stock Is More Undervalued?

BHVN scores higher with a 3.8/10 quality rating vs BDRX's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biodexa Pharmaceuticals plc (BDRX) and Biohaven Ltd. (BHVN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BDRX currently trades at $3.36 with a QOC of 1.7/10, while BHVN trades at $10.24 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).